The Library
Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls
Tools
Dixson, Luanna, Ridler, Khanum, Nichols, Thomas E., Saemann, Philipp G., Auer, Dorothee P., Holsboer, Florian, Muglia, Pierandrea, Matthews, Paul M. and Inkster, Becky. (2011) Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls. Psychoneuroendocrinology, Vol.36 (No.6). pp. 929-934. ISSN 0306-4530
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.psyneuen.2010.12.002
Abstract
Several studies have established links between thyroid gland dysfunction and mood disorders, in particular major depressive disorder (MDD). Preliminary evidence also suggests that thyroid hormone gene variants influence grey matter (GM) volume, which is reportedly altered in patients with MDD. This study tested for associations of single nucleotide polymorphisms (SNPs) in two thyroid hormone transporter genes with regional GM volume differences in a large sample population of patients with recurrent MDD and healthy volunteers.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QH Natural history > QH426 Genetics Q Science > QP Physiology R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
| Divisions: | Faculty of Science > Statistics Faculty of Science > WMG (Formerly the Warwick Manufacturing Group) |
| Library of Congress Subject Headings (LCSH): | Thyroid hormones, Brain -- Magnetic resonance imaging, Depression, Mental, Genetic polymorphisms |
| Journal or Publication Title: | Psychoneuroendocrinology |
| Publisher: | Pergamon |
| ISSN: | 0306-4530 |
| Date: | 2011 |
| Volume: | Vol.36 |
| Number: | No.6 |
| Page Range: | pp. 929-934 |
| Identification Number: | 10.1016/j.psyneuen.2010.12.002 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Funder: | GlaxoSmithKline |
| References: | Avramides, A., Papamargaritis, K., Mavromatis, I., Saddic, G., Vyzantiadis, A., Milonas, I., 1992. Visual evoked potentials in hypothyroid and hyperthyroid patients before and after achievement of euthyroidism. J. Endocrinol. Invest. 15, 749—753. Bauer, M., Goetz, T., Glenn, T., Whybrow, P.C., 2008. The thyroid— brain interaction in thyroid disorders and mood disorders. J. Neuroendocrinol. 20, 1101—1114. Bahls, S.C., Calvalho, G.A., 2004. The relation between thyroid function and depression: a review. Rev. Bras. Psiquiatr. 26 (Suppl 1), 41—49. Cuenco, K.T., Friedland, R., Baldwin, C.T., Guo, J., Vardarajan, B., Lunetta, K.L., Cupples, L.A., Green, R.C., Decarli, C., Farrer, L.A., 2009. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol. Aging 32, 249— 256. Forkel, S.J., de Schotten, T.M., Dell’Acqua, F., Catani, M., 2010. An uniquely human pathways connects frontal and occipital lobes. In: British Chapter ISMRM, Proceedings of the Post-graduate Magnetic Resonance Symposium, Oral Presentation. Abstract 01. Fuchs, O., Farr, N.P., Pohlenz, J., Schmidt, H., 2009. Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation. Dev. Med. Child. Neurol. 51, 240—244. Gillespie, C.F., Nemeroff, C.B., 2005. Hypercortisolemia and depression. Psychosom. Med. 67, 26—28. Guadano-Ferraz, A., Benavides-Piccione, R., Venero, C., Lancha, C., Vennstrom, B., Sandi, C., DeFelipe, J., Bernal, J., 2003. Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behavior and hippocampal circuits. Mol. Psychiatry 8, 30—38. Hayasaka, S., Phan, K.L., Liberzon, I., Worsley, K.J., Nichols, T.E., 2004. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22, 676—687. Howland, R.H., 1993. Thyroid dysfunction in refractory depression: Implications for pathophysiology and treatment. J. Clin. Psychiatry 54, 47—54. Inkster, B., Nichols, T.E., Saemann, P.G., Auer, D.P., Holsboer, F., Muglia, P., Matthews, P.M., 2009. Association of gsk3beta polymorphisms with brain structural changes in major depressive disorder. Arch. Gen. Psychiatry 66, 721—728. Koolschijn, P.C., van Haren, N.E., Lensvelt-Mulders, G.J., Hulshoff Pol, H.E., Kahn, R.S., 2009. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 30, 3719—3735. Krausz, Y., Freedman, N., Lester, H., Barkai, G., Levin, T., Bocher, M., Chisin, R., Lerer, B., Bonne, O., 2007. Brain spect study of common ground between hypothyroidism and depression. Int. J. Neuropsychopharmacol. 10, 99—106. Krausz, Y., Freedman, N., Lester, H., Newman, J.P., Barkai, G., Bocher, M., Chisin, R., Bonne, O., 2004. Regional cerebral blood flow in patients with mild hypothyroidism. J. Nucl. Med. 45, 1712—1715. Larsen, R.P., Davies, T.F., Schlumberger, M.-J., Hay, I.D., 2003. Thyroid physiology and diagnostic evaluation of patients with thyroid disorder. In: Larson, R.P. (Ed.), Williams Textbook of Endocrinology. Saunders, Philadelphia, pp. 331—373. Lazarus, J.H., 2009. Lithium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23, 723—733. Lupien, S.J., Leon, M., Santi, S., Convit, A., Tarshish, C., Nair, N.P.V., Thakur, M., McEwen, B.S., Hauger, R.L., Meaney, M.J., 1998. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1, 69—73. Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen, G., Manji, H.K., 2000. Lithium-induced increase in human brain grey matter. Lancet 356, 1241—1242 (erratum). Morreale de Escobar, G., Obregon, M.J., Escobar del Rey, F., 2004. Role of thyroid hormone during early brain development. Eur. J. Endocrinol. 151 (Suppl. 3), U25—U37. Nagamachi, S., Jinnouchi, S., Nishii, R., Ishida, Y., Fujita, S., Futami, S., Kodama, T., Tamura, S., Kawai, K., 2004. Cerebral blood flow abnormalities induced by transient hypothyroidism after thyroidectomy–— analysis by tc-99m-hmpao and spm96. Ann. Nucl. Med. 18, 469—477. Rovet, J.F., Simic, N., 2008. The role of transient hypothyroxinemia of prematurity in development of visual abilities. Sem. Perinatol. 32, 431—437. Rovet, J.F., Skocic, J., Khan, S., 2009. Grey matter reductions in children with congenital hypothyroidism, a voxel based morphometry (VBM study). In: American Thyroid Association 80th Annual Meeting, Oral Presentation. Abstract 09. Rush, A.J., 2007. The varied clinical presentations of major depressive disorder. J. Clin. Psychiatry 68 (Suppl. 8), 4—10. Schwartz, C.E., Stevenson, R.E., 2007. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 21, 307—321. Schweizer, U., Weitzel, J.M., Schomburg, L., 2008. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol. Cell. Endocrinol. 289, 1—9. Starkman, M.N., Giordani, B., Gebarski, S.S., Berent, S., Schork, M.A., Schteingart, D.E., 1999. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol. Psychiatry 46, 1595—1602. Tozzi, F., Prokopenko, I., Perry, J.D., Kennedy, J.L., McCarthy, A.D., Holsboer, F., Berrettini, W., Middleton, L.T., Chilcoat, H.D., Muglia, P., 2008. Family history of depression is associated with younger age of onset in patients with recurrent depression. Psychol. Med. 38, 641—649. Treadway, M.T., Grant, M.M., Ding, Z., Hollon, S.D., Gore, J.C., Shelton, R.C., 2009. Early adverse events, HPA activity and rostral anterior cingulate volume in MDD. PLoS One 4, 4887. van der Deure, W.M., Appelhof, B.C., Peeters, R.P., Wiersinga, W.M., Wekking, E.M., Huyser, J., Schene, A.H., Tijssen, J.G., Hoogendijk, W.J., Visser, T.J., Fliers, E., 2008. Polymorphisms in the brain-specific thyroid hormone transporter oatp1c1 are associated with fatigue and depression in hypothyroid patients. Clin. Endocrinol. (Oxf.) 69, 804—811. Venero, C., Guadano-Ferraz, A., Herrero, A.I., Nordstrom, K., Manzano, J., de Escobar, G.M., Bernal, J., Vennstrom, B., 2005. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev. 19, 2152—2163. Zoeller, R.T., Rovet, J., 2004. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J. Neuroendocrinol. 101, 809—818. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/41132 |
Actions (login required)
![]() |
View Item |
Tools
Tools

